D.E. Shaw & Co’s MediciNova MNOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-12,847
Closed -$49K 5586
2021
Q3
$49K Sell
12,847
-12,024
-48% -$45.7K ﹤0.01% 4823
2021
Q2
$106K Sell
24,871
-7,831
-24% -$33.7K ﹤0.01% 4546
2021
Q1
$165K Buy
+32,702
New +$190K ﹤0.01% 3884
2020
Q4
Sell
-10,499
Closed -$55K 4066
2020
Q3
$55K Sell
10,499
-56,017
-84% -$323K ﹤0.01% 3745
2020
Q2
$361K Sell
66,516
-3,828
-5% -$20.3K ﹤0.01% 3549
2020
Q1
$262K Sell
70,344
-196,519
-74% -$1.02M ﹤0.01% 3538
2019
Q4
$1.79M Sell
266,863
-135,515
-34% -$1.02M ﹤0.01% 2564
2019
Q3
$3.27M Buy
402,378
+5,152
+1% +$45.9K ﹤0.01% 1988
2019
Q2
$3.81M Buy
397,226
+95,146
+31% +$1M ﹤0.01% 1793
2019
Q1
$2.5M Buy
302,080
+35,737
+13% +$312K ﹤0.01% 2003
2018
Q4
$2.18M Buy
266,343
+91,812
+53% +$916K ﹤0.01% 2090
2018
Q3
$2.15M Buy
174,531
+66,641
+62% +$670K ﹤0.01% 2145
2018
Q2
$850K Buy
107,890
+72,982
+209% +$755K ﹤0.01% 2799
2018
Q1
$407K Buy
+34,908
New +$348K ﹤0.01% 2979
2017
Q4
Sell
-12,542
Closed -$80K 3679
2017
Q3
$80K Buy
+12,542
New +$66.7K ﹤0.01% 3380
2017
Q1
Sell
-55,348
Closed -$343K 3487
2016
Q4
$343K Buy
+55,348
New +$390K ﹤0.01% 3057
2016
Q3
Sell
-34,959
Closed -$262K 3477
2016
Q2
$262K Buy
+34,959
New +$253K ﹤0.01% 3087

Other funds holding MNOV

D.E. Shaw & Co's MNOV Position: Q4 2021 in Review

D.E. Shaw & Co sold out of MediciNova (MNOV) in Q4 2021, closing a stake of 12,847 shares — an estimated $49K sold.

D.E. Shaw & Co first reported a position in MNOV in Q2 2016 and held it in 17 quarters. The position peaked at $3.81M in Q2 2019. 42 funds tracked by Wall St. Rank hold MNOV as of Q4 2021.

  • D.E. Shaw & Co reported no remaining MediciNova position as of Q4 2021 after selling out during the quarter.
  • D.E. Shaw & Co sold 12,847 MediciNova shares in Q4 2021, an estimated $49K.
  • D.E. Shaw & Co first reported a position in MediciNova in Q2 2016 and held it in 17 quarters.
  • D.E. Shaw & Co's MediciNova position peaked at $3.81M in Q2 2019.
  • 42 funds tracked by Wall St. Rank held MediciNova as of Q4 2021.

Based on D.E. Shaw & Co's 13F filing for Q4 2021, filed 14 Feb 2022.